Monaco Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Monaco Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.35M	Sell	221,286 -20,000	-8%	-$131K	0.11%	37
2026 Q1	$1.67M	Buy	241,286 +45,000	+23%	+$347K	0.31%	41
2025 Q4	$1.73M	Sell	196,286 -51,519	-21%	-$284K	0.3%	52
2025 Q3	$1.24M	Sell	247,805 -57,195	-19%	-$265K	0.08%	59
2025 Q2	$1.44M	Sell	305,000 -20,000	-6%	-$87.5K	0.25%	54
2025 Q1	$1.49M	Sell	325,000 -67,262	-17%	-$314K	0.3%	41
2024 Q4	$1.88M	Buy	392,262 +188,836	+93%	+$907K	0.27%	44
2024 Q3	$954K	Buy	203,426 +10,500	+5%	+$56.3K	0.14%	57
2024 Q2	$1.09M	Buy	+192,926	New	+$996K	0.17%	41
2024 Q1	–	Sell	-85,000	Closed	-$359K	–	85
2023 Q4	$359K	Sell	85,000 -50,000	-37%	-$202K	0.11%	68
2023 Q3	$583K	Buy	+135,000	New	+$750K	0.17%	60

Other funds holding VNDA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Monaco Asset Management's VNDA Position: Q2 2026 in Review

Monaco Asset Management reduced its Vanda Pharmaceuticals (VNDA) stake by 8.3% in Q2 2026, selling an estimated $131K and leaving 221,286 shares worth $1.35M. The position accounts for 0.11% of the portfolio, ranked #37.

Monaco Asset Management first reported a position in VNDA in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.88M in Q4 2024. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

Monaco Asset Management held 221,286 shares of Vanda Pharmaceuticals worth $1.35M as of Q2 2026.
Monaco Asset Management sold 20,000 Vanda Pharmaceuticals shares in Q2 2026, an estimated $131K.
Vanda Pharmaceuticals made up 0.11% of Monaco Asset Management's portfolio in Q2 2026, its #37 holding.
Monaco Asset Management first reported a position in Vanda Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
Monaco Asset Management's Vanda Pharmaceuticals position peaked at $1.88M in Q4 2024.
172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Monaco Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.